Latest Heart valve Stories

Research from Karolinska Institutet in Sweden shows, that a specific inflammatory factor may be important in the development of the heart valve disease aortic stenosis. The results suggest that anti-inflammatory medication could be a possible new treatment.Aortic stenosis is the most common heart valve disease, which is caused by calcium deposits and a narrowing of the aortic valve. This is typically seen in the elderly, but can also be caused by a congenital defect. Aortic stenosis is...

ANN ARBOR, Mich., March 11, 2011 /PRNewswire-USNewswire/ -- The University of Michigan Cardiovascular Center, a leader in heart valve replacement, will participate in a national clinical trial to offer patients a less invasive approach to replacing diseased aortic valves. The nationally ranked U-M is among 40 sites in the nation selected for the Medtronic CoreValve U.S. Pivotal trial, a study that will examine an investigational alternative to open heart surgery for patients with severe...

Two patients who had severe aortic stenosis are "recovering well" - only days after the minimally invasive procedure DETROIT, March 1, 2011 /PRNewswire-USNewswire/ -- The Detroit Medical Center (DMC) Cardiovascular Institute (CVI) has completed the first two transcatheter aortic valve implants (TAVI) ever achieved in Michigan. The procedures are a part of CVI's participation in the Medtronic CoreValve® U.S. Clinical Trial. This multi-state trial will evaluate a new, non-surgical...

Oregon Health & Science University is one of a few centers in the nation qualified to use the first FDA-approved pulmonary heart valve that can be implanted through the legThe pediatric cardiac team at Oregon Health & Science University Doernbecher Children's Hospital is the first in the region and one of a handful in the nation to implant a pulmonary heart valve without open-heart surgery.To date, four patients have received the landmark valve in the OHSU Pediatric and Adult...

Complicated Surgery simplified by New Device LONDON, ON, Jan. 24 /PRNewswire/ - Doctors at London Health Sciences Centre (LHSC) are the first in the world to use a new implantable surgical device that promises to revolutionize aortic valve bypass surgery. On November 3, 2010, LHSC's cardiac surgery team led by Drs. Bob Kiaii and Linrui Guo successfully performed an aortic valve bypass using a specialized Aortic Valve Bypass (AVB) device. This was done to treat a patient with...

Cardiac Surgery Market to Reach Over $4.4 Billion by 2017 VANCOUVER, Jan. 18 /PRNewswire/ - According to a new report by iData Research (www.idataresearch.net), the leading global authority in medical device and pharmaceutical market research, percutaneous aortic valve replacement (PAVR) and percutaneous mitral valve repair (PMVR) devices are expected to enter the U.S. market in 2011 and grow to almost $1.3 billion by 2017. Adoption of these devices for treating mitral regurgitation,...

ZHENGZHOU, China, Jan. 18, 2011 /PRNewswire-Asia-FirstCall/ -- China Valves Technology, Inc. (Nasdaq: CVVT) ("China Valves" or the "Company"), a leading Chinese metal valve manufacturer, today announced that its gate and check valves used in the core island of nuclear power plants successfully passed all tests administered by China Institute of Atomic Energy ("CIAE"), the primary nuclear science and technology research institute in China, and Nuclear Power Institute of China ("NPIC"), the...

ROSLYN, N.Y., Jan. 11, 2011 /PRNewswire/ -- Newell Robinson, M.D., Chairman of the Department of Cardiothoracic & Vascular Surgery; George Petrossian, M.D., Director of Interventional Cardiovascular Procedures; Andrew Berke, M.D., interventional cardiologist; and Roberto Colangelo, M.D., cardiothoracic surgeon at St. Francis Hospital, The Heart Center® are part of the medical team that is testing a device that may offer new hope for patients with symptomatic, severe aortic stenosis....

NATICK, Mass., Jan. 4, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of Sadra Medical, Inc. of Los Gatos, California. The transaction follows the definitive merger agreement announced on November 19, 2010. Under the terms of the agreement, Boston Scientific paid $193 million to acquire the remaining 86 percent of Sadra Medical's equity not already owned by Boston Scientific. Additional payments of up to $193 million are...

MOUNTAIN VIEW, Calif., Dec. 21 2010 /PRNewswire/ -- El Camino Hospital today announced its first patient implant in the Medtronic CoreValve® U.S. Clinical Trial. El Camino Hospital is one of the first of 40 hospitals across the U.S. to participate in the trial, which is evaluating a revolutionary non-surgical, less-invasive procedure as a treatment alternative to open-heart surgery for patients with severe aortic stenosis. "The Heart and Vascular Institute at El Camino Hospital is proud...